Stock Rich List
Nasdaq: SMMT

Summit Therapeutics insiders

The officers, directors and 10% owners of Summit Therapeutics Inc. who hold the most stock, valued at the live SMMT price.

$10.57
SMMT today +$70K (+0.67%)
Market closed. Prices as of Nov 19, 4:04 PM ET
Ranked insiders
5
Their SMMT stock
$6.83B
Market value
$8.45B
Held by ranked insiders
80.8%

Insiders by value of SMMT holdings

SEC ownership page
#InsiderRoleSharesValueOf companyOverall rank
1Robert W. DugganCo-Chief Executive Officer591,972,684$6.26B74.0%34th
2Yu XiaDirector32,057,147$339M4.01%627th
3Mahkam ZanganehCo-Chief Executive Officer18,619,805$197M2.33%795th
4Manmeet SoniCOO and CFO3,224,375$34.1M0.40%3414th
5Ankur DhingraChief Financial Officer394,485$4.2M<0.1%6885th

Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Summit Therapeutics; see each profile for the filing.